The unexpected finding of CNS autoantibodies in GBA1 mutation carriers with atypical parkinsonism
J Neuropathol Exp Neurol
.
2023 Aug 21;82(9):818-820.
doi: 10.1093/jnen/nlad055.
Authors
Francesca Di Biasio
1
,
Giulia Lazzeri
2
3
,
Edoardo Monfrini
2
3
,
Paola Mandich
1
4
5
,
Lucia Trevisan
4
5
,
Silvia Morbelli
1
4
,
Tiziana Benzi Markushi
4
,
Laura Avanzino
1
6
,
Alessio Di Fonzo
2
Affiliations
1
Neurology Unit, IRCCS Policlinico San Martino, Genoa, Italy.
2
Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy.
3
Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
4
Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
5
Medical Genetics Unit, IRCCS San Martino Hospital, Genoa, Italy.
6
Section of Human Physiology, Department of Experimental Medicine, University of Genoa, Genoa, Italy.
PMID:
37428899
DOI:
10.1093/jnen/nlad055
No abstract available
Publication types
Letter
MeSH terms
Autoantibodies*
Glucosylceramidase / genetics
Humans
Mutation / genetics
Parkinsonian Disorders* / genetics
alpha-Synuclein / genetics
Substances
Autoantibodies
Glucosylceramidase
alpha-Synuclein